|
(b)(4).Date sent to the fda: 02/20/2019.Investigation summary: it was reported that the device had labeling identification issues.An unopened box with two different labels of product codes m8710 and m8701, lot mgh292 was returned for analysis.The box contains twelve unopened samples and these product codes are multi-strands and requirement four strands double armed per packet.During the visual inspection of sample, a mismatched between labels on box (code m8701, lot mgh292) and code m8710 were observed.For this reason, a characterization of samples was conducted, and the following was observed: twelve unopened overwraps of product code m8701, lot mgh292 were examined and no defects were found on the packages.The samples were opened, and contains four strands per packet, the swage and attachment area of the needles were as expected.Also, all samples were examined by needle characteristic on point type, needle type and needle curvature and suture characteristic and the product contained in each packet belong to product code m8701, lot mgh292.The manufacturing records were reviewed, and the manufacturing/packaging criteria were met prior to the release of this batch.According the sample condition, the assignable cause of the packaging labeling identification is mixed labels.A picture of the sample was received for analysis.Upon visual inspection of the picture, a closed sample of product code m8710 with lot# mgh292 with a chinese label with a mismatch of the product code could be observed.However, no conclusion could be reached as the device was not returned for analysis.
|